1. Home
  2. GLXG vs CTXR Comparison

GLXG vs CTXR Comparison

Compare GLXG & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLXG
  • CTXR
  • Stock Information
  • Founded
  • GLXG 2013
  • CTXR 2007
  • Country
  • GLXG Hong Kong
  • CTXR United States
  • Employees
  • GLXG N/A
  • CTXR N/A
  • Industry
  • GLXG
  • CTXR Biotechnology: Pharmaceutical Preparations
  • Sector
  • GLXG
  • CTXR Health Care
  • Exchange
  • GLXG NYSE
  • CTXR Nasdaq
  • Market Cap
  • GLXG 16.0M
  • CTXR 14.6M
  • IPO Year
  • GLXG 2024
  • CTXR N/A
  • Fundamental
  • Price
  • GLXG $0.58
  • CTXR $0.84
  • Analyst Decision
  • GLXG
  • CTXR Strong Buy
  • Analyst Count
  • GLXG 0
  • CTXR 2
  • Target Price
  • GLXG N/A
  • CTXR $54.50
  • AVG Volume (30 Days)
  • GLXG 4.3M
  • CTXR 679.0K
  • Earning Date
  • GLXG 05-16-2025
  • CTXR 05-13-2025
  • Dividend Yield
  • GLXG N/A
  • CTXR N/A
  • EPS Growth
  • GLXG N/A
  • CTXR N/A
  • EPS
  • GLXG 0.04
  • CTXR N/A
  • Revenue
  • GLXG $3,858,088.00
  • CTXR N/A
  • Revenue This Year
  • GLXG N/A
  • CTXR N/A
  • Revenue Next Year
  • GLXG N/A
  • CTXR N/A
  • P/E Ratio
  • GLXG $12.93
  • CTXR N/A
  • Revenue Growth
  • GLXG N/A
  • CTXR N/A
  • 52 Week Low
  • GLXG $0.55
  • CTXR $0.81
  • 52 Week High
  • GLXG $16.93
  • CTXR $26.25
  • Technical
  • Relative Strength Index (RSI)
  • GLXG N/A
  • CTXR 28.63
  • Support Level
  • GLXG N/A
  • CTXR $0.81
  • Resistance Level
  • GLXG N/A
  • CTXR $1.02
  • Average True Range (ATR)
  • GLXG 0.00
  • CTXR 0.09
  • MACD
  • GLXG 0.00
  • CTXR 0.01
  • Stochastic Oscillator
  • GLXG 0.00
  • CTXR 10.09

About GLXG GALAXY PAYROLL GROUP LTD

Galaxy Payroll Group Ltd provides payroll outsourcing, employment, consultancy, and market research services based in Hong Kong. Its client base includes retail, trading, industrial, IT, financial, and professional services industries. Geographically, the company derives maximum revenue from its clients in the People's Republic of China and the rest from Hong Kong, Macau, Taiwan, Japan, Thailand, Singapore, and other countries.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Share on Social Networks: